Cellini, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 2.867
EU - Europa 2.168
AS - Asia 920
AF - Africa 39
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 6.008
Nazione #
US - Stati Uniti d'America 2.812
SE - Svezia 723
DE - Germania 388
SG - Singapore 365
IT - Italia 303
CN - Cina 281
IE - Irlanda 216
FR - Francia 153
ID - Indonesia 130
UA - Ucraina 86
FI - Finlandia 77
IN - India 67
RU - Federazione Russa 63
CA - Canada 54
CZ - Repubblica Ceca 40
GB - Regno Unito 39
TR - Turchia 34
CI - Costa d'Avorio 30
BE - Belgio 21
IR - Iran 15
NL - Olanda 12
HK - Hong Kong 11
CH - Svizzera 7
PL - Polonia 7
JP - Giappone 5
AT - Austria 4
ES - Italia 4
MA - Marocco 4
RO - Romania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AU - Australia 3
BR - Brasile 3
CL - Cile 3
DK - Danimarca 3
GR - Grecia 3
LT - Lituania 3
LU - Lussemburgo 3
RS - Serbia 3
BG - Bulgaria 2
DZ - Algeria 2
EU - Europa 2
HR - Croazia 2
JO - Giordania 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MY - Malesia 2
SC - Seychelles 2
CM - Camerun 1
CY - Cipro 1
IL - Israele 1
NO - Norvegia 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
VN - Vietnam 1
Totale 6.008
Città #
Chandler 800
Singapore 293
Ashburn 285
Dublin 216
Jakarta 129
New York 125
Boston 111
Princeton 102
San Mateo 95
Milan 81
Beijing 75
Wilmington 70
Jacksonville 68
Marseille 64
Rome 56
Helsinki 53
Moscow 48
Ann Arbor 47
Nanjing 41
Bremen 40
Los Angeles 36
Leesburg 34
Dearborn 32
Izmir 32
Munich 32
Brno 31
Fairfield 31
Abidjan 30
Woodbridge 26
Redwood City 24
Toronto 24
Pune 23
Brussels 21
North York 21
Lawrence 20
Augusta 19
Seattle 19
Chicago 17
Houston 17
Phoenixville 15
Washington 14
Cattolica 13
Nanchang 13
Norwalk 13
Nürnberg 13
Leawood 12
Boardman 11
Fremont 11
San Diego 11
Shenyang 11
Falls Church 10
Paris 9
Hong Kong 8
Jiaxing 8
Andover 7
Zhengzhou 7
Ardabil 6
Changsha 6
Detroit 6
Falkenstein 6
Florence 6
Kunming 6
Ottawa 6
Sergii 6
University Park 6
Amsterdam 5
Indiana 5
London 5
Mountain View 5
Naples 5
Atlanta 4
Bologna 4
Cambridge 4
Dresden 4
Guangzhou 4
Hefei 4
Kish 4
Kraków 4
Belgrade 3
Brdo 3
Frankfurt am Main 3
Hangzhou 3
Jinhua 3
Lappeenranta 3
Parsippany 3
Redmond 3
Sacramento 3
San Cipriano Picentino 3
Saronno 3
Shanghai 3
São Paulo 3
Tianjin 3
Verbania 3
Vienna 3
Zurich 3
Agadir 2
Algiers 2
Berlin 2
Breganze 2
Brescia 2
Totale 3.646
Nome #
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection. 141
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 138
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 115
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 112
Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach 111
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 108
Survival after radiotherapy in gastric cancer: systematic review and meta-analysis. 89
Delta radiomics for rectal cancer response prediction with hybrid 0.35 T magnetic resonance-guided radiotherapy (MRgRT): a hypothesis-generating study for an innovative personalized medicine approach 86
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 85
Underuse of brachytherapy for the treatment of dysphagia owing to esophageal cancer. An Italian survey 85
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 82
Multi-object tracking in MRI-guided radiotherapy using the tracking-learning-detection framework 78
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 77
Development of a modelling to correlate site and diameter of brain metastases with hippocampal sparing using volumetric modulated Arc therapy 73
Effect of beta-carotene-rich tomato lycopene beta-cyclase ( tlcy-b) on cell growth inhibition in HT-29 colon adenocarcinoma cells. 71
Identification of the most significant magnetic resonance imaging (MRI) radiomic features in oncological patients with vertebral bone marrow metastatic disease: a feasibility study 70
Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial 69
IMproved MAnagement (IM-MA study) in cancer-related pain: the value of a joint approach by an integrated team of radiotherapist and anesthetist 69
Individually optimized stereotactic radiotherapy for pancreatic head tumors: A planning feasibility study 67
Role of chemoradiation (CRT) in the adjuvant treatment of radically resected pancreatic cancer (PC) patients (pts): a mono-institutional retrospective analysis 67
Online adaptive magnetic resonance guided radiotherapy for pancreatic cancer: state of the art, pearls and pitfalls 67
Targeted Therapies in Combination with Radiotherapy in Oesophageal and Gastroesophageal Carcinoma 66
Low Tesla magnetic resonance guided radiotherapy for locally advanced cervical cancer: first clinical experience 66
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer 66
An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer 65
A new frontier of image guidance: Organs at risk avoidance with MRI-guided respiratory-gated intensity modulated radiotherapy: Technical note and report of a case 65
Hybrid Tri-Co-60 MRI radiotherapy for locally advanced rectal cancer: An in silico evaluation 64
Diffusion weighted imaging (DWI) and apparent diffusion coefficient (ADC) values for detection of malignant vertebral bone marrow lesions. 63
ESTRO ACROP guidelines for the delineation of lymph nodal areas in upper gastrointestinal malignancies 63
New perspectives in treatment decision for integrated management of rectal cancer: multimodal research for multimodal treatments 62
Role of microRNA in response to ionizing radiations: evidences and potential impact on clinical practice for radiotherapy 62
Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma 62
On the feasibility of distributed process mining in healthcare 62
Identification of the most significant magnetic resonance imaging (MRI) radiomic features in oncological patients with vertebral bone marrow metastatic disease: a feasibility study. 61
MR-guided radiotherapy in rectal cancer: First clinical experience of an innovative technology 61
Use of Indirect Target Gating in Magnetic Resonance-guided Liver Stereotactic Body Radiotherapy: Case Report of an Oligometastatic Patient 61
Short course accelerated radiation therapy (SHARON) in palliative treatment of advanced solid cancer in older patients: A pooled analysis 60
Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival 60
Predicting tumour motion during the whole radiotherapy treatment: a systematic approach for thoracic and abdominal lesions based on real time MR 58
Surgery: neoadjuvant chemoradiation and sphincter preservation 57
On the accuracy of bulk synthetic CT for MR-guided online adaptive radiotherapy 57
The role of palliative interventional radiotherapy (brachytherapy) in esophageal cancer: An AIRO (Italian Association of Radiotherapy and Clinical Oncology) systematic review focused on dysphagia-free survival 57
Project for interventional Oncology LArge-database in liveR Hepatocellular carcinoma - Preliminary CT-based radiomic analysis (POLAR Liver 1.1) 57
Correction to: Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients (Journal of Cancer Research and Clinical Oncology, (2021), 147, 3, (661-667), 10.1007/s00432-020-03411-7) 56
Diffusion weighted imaging (DWI) and apparent diffusion coefficient (ADC) values for detection of malignant vertebral bone marrow lesions 55
Robotic radiosurgery in pancreatic cancer: A systematic review 54
A “SHort course Accelerated RadiatiON therapy” (SHARON) During and Beyond the COVID-19 Pandemic 54
Personalized Automation of Treatment Planning for Linac-Based Stereotactic Body Radiotherapy of Spine Cancer 54
Modern Management of Esophageal Cancer: Radio-Oncology in Neoadjuvancy, Adjuvancy and Palliation 53
The impact of radiomics in diagnosis and staging of pancreatic cancer 52
Evaluation of a simplified optimizer for MR-guided adaptive RT in case of pancreatic cancer 51
Experimental evaluation of the impact of low tesla transverse magnetic field on dose distribution in presence of tissue interfaces 51
Radiotherapy or Chemoradiation in Unresectable Biliary Cancer: A Retrospective Study 49
Palliative radiotherapy indications during the COVID-19 pandemic and in future complex logistic settings: the NORMALITY model 49
MRI-guided stereotactic radiation therapy for hepatocellular carcinoma: a feasible and safe innovative treatment approach 49
A new standardized data collection system for brain stereotactic external radiotherapy: The PRE.M.I.S.E project 48
Clinical Studies on Ultrafractionated Chemoradiation: A Systematic Review 48
Assessing the conformity to clinical guidelines in oncology: An example for the multidisciplinary management of locally advanced colorectal cancer treatment 48
Radiation therapy for prostate cancer: What's the best in 2021 48
Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients 47
Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients 47
Magnetic resonance–guided radiotherapy feasibility in elderly cancer patients: proposal of the MASTER scoring system 47
Multidisciplinary Management of Rectal Cancer: Questions and Answers 47
Clinical Target Volume in Biliary Carcinoma: A Systematic Review of Pathological Studies. 46
MR-guidance in clinical reality: current treatment challenges and future perspectives 46
Systematic review of stereotactic body radiotherapy for nodal metastases 46
Magnetic resonance imaging (MRI) compared with computed tomography (CT) for interobserver agreement of gross tumor volume delineation in pancreatic cancer: a multi-institutional contouring study on behalf of the AIRO group for gastrointestinal cancers 45
Case Report: A Case Report of Stereotactic Ventricular Arrhythmia Radioablation (STAR) on Large Cardiac Target Volume by Highly Personalized Inter- and Intra-fractional Image Guidance 45
Definition of local recurrence site in resected pancreatic adenocarcinoma: A multicenter study (dolores-1) 45
An Intensive Educational Intervention Significantly Improves the Adoption of Single Fractionation Radiotherapy in Uncomplicated Bone Metastases 45
Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis 44
Ablative Radiotherapy (ART) for Locally Advanced Pancreatic Cancer (LAPC): Toward a New Paradigm? 44
Stereotactic body radiotherapy for painful spinal metastases 44
Adding Ipsilateral V20 and V30 to Conventional Dosimetric Constraints Predicts Radiation Pneumonitis in Stage IIIA-B NSCLC Treated With Combined-Modality Therapy 44
Radiotherapy for benign disorders: Current use in clinical practice 43
On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations 43
Multimodal treatment of resectable pancreatic ductal adenocarcinoma 42
Role of neoadjuvant radiochemotherapy for esophageal cancers over pre/peri-operative chemotherapy in the era of COVID-19 and beyond 42
Application of a practical method for the isocenter point in vivo dosimetry by a transit signal 40
Prognostic Score in Radiotherapy Practice for Palliative Treatments (PROPHET) Study for Bone Metastases: An Investigation Into the Clinical Effect on Treatment Prescription 39
Basics and frontiers on pancreatic cancer for radiation oncology: Target delineation, SBRT, SIB technique, MRgRT, particle therapy, immunotherapy and clinical guidelines 39
Palliative short-course radiotherapy in advanced pelvic cancer: A phase II study (SHARON project) 39
Epid cine acquisition mode for in vivo dosimetry in dynamic arc radiation therapy 38
Current treatment of rectal cancer adapted to the individual patient. 37
Low Tesla MRI in-Room Gating during Radiotherapy 37
Tumor regression in mesorectal lymphnodes after neoadjuvant chemoradiation for rectal cancer 37
Accelerated middle half body radiotherapy in bone metastases from prostate cancer: A phase I study (SHARON project) 36
Whole-breast irradiation: A subgroup analysis of criteria to stratify for prone position treatment 36
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma 35
Critical review of multidisciplinary non-surgical local interventional ablation techniques in primary or secondary liver malignancies 35
Clinical Target Volume in Biliary Carcinoma: A Systematic Review of Pathological Studies 34
Prioritization on palliative radiotherapy during the COVID-19 pandemic (and beyond) 34
Stereotactic body radiotherapy vs conventionally fractionated chemoradiation in locally advanced pancreatic cancer: A multicenter case-control study (PAULA-1) 34
Higher biologically effective dose predicts survival in SBRT of pancreatic cancer: A multicentric analysis (PAULA-1) 34
Molecularly targeted therapy and radiotherapy in the management of localized gastrointestinal stromal tumor (GIST) of the rectum: A case report 34
Beams Arrangement in Non-Small Cell Lung Cancer (NSCLC) According to PTV and Dosimetric Parameters Predictive of Pneumonitis 33
Combined treatments in gastric cancer: radiotherapy. 32
The role of interventional radiotherapy (brachytherapy) in stage i esophageal cancer: An AIRO (Italian Association of Radiotherapy and Clinical Oncology) systematic review 30
Ventricular tachycardia ablation through radiation therapy (VT-ART) consortium: Concept description of an observational multicentric trial via matched pair analysis 28
Neoadjuvant radiochemotherapy and perioperative chemotherapy do not represent a standard at the same priority level for esophageal adenocarcinomas (with regard to 'Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up') 27
Totale 5.654
Categoria #
all - tutte 38.293
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.293


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020319 0 0 0 0 0 33 35 14 103 18 90 26
2020/2021263 10 23 15 23 37 16 29 4 30 26 47 3
2021/2022896 57 19 42 61 26 30 15 120 37 45 248 196
2022/20232.278 334 276 168 353 136 272 123 178 263 52 91 32
2023/20241.235 42 325 47 151 75 200 88 48 6 36 109 108
2024/2025606 57 53 171 66 210 49 0 0 0 0 0 0
Totale 6.159